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C
arl Moore, who greatly impacted my 
life as a scientist and clinician, was a 
man much revered and respected at 
Washington University in St. Louis. 
Born in 1908 into a working-class family, he was 
instilled by his very humble beginnings with the 
basic values of hard work, honesty, and selfl ess-
ness. While he was growing up, he labored at 
many jobs, from cleaning houses to delivering 
medicines for the local pharmacist. Remark-
ably, he graduated from high school when he 
was 15 years old. Th en, in 1932, in a single year, 
he completed all the requirements of his medi-
cal education at Washington University. His 
physiology professor, Joseph Erlanger, encour-
aged the young Dr. Moore to consider medical 
research as a profession, and, aft er joining the 
faculty in 1938, Dr. Moore set up his own hema-
tology research laboratory, in which his classic 
studies of iron metabolism were performed. He 
was elected to the National Academy of Sciences 
in 1970. Dr. Moore served on advisory boards 
and accepted several administrative positions 
during his lifelong affi  liation with Washington 
University, including those of dean, vice-chancel-
lor for medical aff airs, and head of the Depart-
ment of Medicine. As head of the department, he 
recruited an outstanding staff  of scientists, but he 
also encouraged universal respect of those physi-
cians who devoted most of their time to clinical 
activities and teaching.
In the late 1950s, nephrology did not exist as 
a specialty, although there was a group of indi-
viduals around the world who were interested in 
various aspects of kidney function, pathology, 
and clinical diseases. Although the evolution of 
the subspecialty of nephrology and my personal 
evolution as a physician and researcher did not 
come together at Washington University in St. 
Louis until 1961, the two are inextricably inter-
twined and forever linked.
In 1956, Dr. Neal Bricker was recruited by Dr. 
Moore to be the fi rst director of the Renal Divi-
sion at Washington University School of Medicine 
and thus began a long association with the medi-
cal school. Dr. Bricker obtained his BA and MD 
from the University of Colorado. Aft erward he 
served a period of house-staff  training from 1949 
to 1952 at Bellevue Hospital of New York Uni-
versity and as a clinical assistant at Fitzsimmons 
Army Hospital at the University of Colorado 
School of Medicine from 1952 to 1954. During 
this period, Dr. Bricker and Dr. Patton conducted 
two classic studies on polycystic kidney disease. 
One dealt with the composition of cyst fl uid and 
the other with the eff ects of surgical decompres-
sion of cysts on renal function in patients with 
polycystic kidney disease.
Dr. Bricker served from 1954 to 1955 as a senior 
assistant resident at the Peter Bent Brigham Hos-
pital, Harvard Medical School, and subsequently 
(1955 to 1956) was an instructor of medicine 
and associate director of the Cardiorenal Labo-
ratory at Harvard Medical School. At the Peter 
Bent Brigham Hospital, Dr. Bricker studied the 
eff ects of renal denervation on renal function 
in the fi rst successful kidney transplant in the 
United States between identical siblings. In sub-
sequent studies, he and his colleagues examined 
the functional capacity of the denervated kidney 
autotransplanted in the dog. He also published a 
classic report on post-obstructive diuresis and its 
potential mechanisms.
In 1957, Dr. Bricker was an assistant professor 
in medicine, and by 1965 he had been promoted 
to professor of medicine. He served as director 
of the Renal Division at Washington University 
School of Medicine from 1956 to 1972. During 
his 16 years at Washington University School of 
Medicine, Dr. Bricker formulated the ideas and 
conceived the experiments that provided the basis 
for a broader understanding of the pathophysi-
ology of chronic renal disease and uremia. Th e 
intact-nephron hypothesis, which he fi rst formu-
lated in detail in the American Journal of Medicine 
in 1960,1 provided a framework for the logical 
understanding of the changes in renal function 
that occur in experimental models of chronic 
renal disease. Dr. Bricker and the staff of the 
Renal Division at Washington University School 
of Medicine described in a systematic manner the 
adaptive changes in renal function, the systemic 
adaptations, the changes in control systems, and 
the changes in homeostasis that occur during the 
course of progressive renal disease, culminating 
in uremia.2–10 Dr. Bricker elegantly detailed the 
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undesirable eff ects of some of these adaptations and their contri-
bution to the pathophysiology of uremia in a report published in 
the New England Journal of Medicine.11 Th ese seminal observa-
tions on the pathophysiology of renal disease and adaptations 
that occur both in the kidney and systemically as renal function 
decreases provided a marked impetus for subsequent studies by 
many laboratories on the pathophysiological eff ects of chronic 
renal disease. A classic study that evolved during Dr. Bricker’s 
tenure as director of the Renal Division was Dr. Eduardo Slat-
opolsky’s work on defi ning the control of phosphate excretion 
in uremia.6 Dr. Slatopolsky developed one of the fi rst radioim-
munoassays for parathyroid hormone and became known as a 
world authority in mineral metabolism.
I joined the Department of Medicine at Washington University 
School of Medicine as a renal fellow in 1961, with the planned 
intention of working with Dr. Bricker. When I arrived in St. Louis 
to begin my studies, Dr. Bricker was out of the country. Dr. Peter 
Morrin gave me a few days of orientation and instruction in per-
forming hemodialysis, and then he, too, left  the country. I found 
myself the lone physician in the Renal Division until Dr. Bricker 
returned from Europe six weeks later.
During those early months at the University, I joined Dr. 
Moore’s famous Saturday morning clinical rounds. I admired his 
personal interest in patients, families, and staff . He was impressed 
by my interest and participation in bedside discussions. Th rough 
the years Dr. Moore became both a mentor and a friend.
Many of those initial days were spent with extended hours of 
clinical duties, which left  no less than the remainder of my 20-
hour day to pursue my true passion: research. One of the fi rst 
studies that Dr. Bricker and I published appeared in the American 
Journal of Physiology.12 Th is was the fi rst of many articles Dr. 
Bricker and I collaborated on that dealt with sodium transport. 
Dr. Bricker had spent many months in Denmark studying with 
Professor Ussing the active transport of sodium as the source of 
electric current in the frog.
In 1971, Dr. Bricker and I coauthored a chapter on obstruc-
tive nephropathy for the second edition of Strauss and Welt’s 
Diseases of the Kidney.13 Th is further enhanced what has proven 
to be my long-term interest in the pathophysiology of obstruc-
tive nephropathy.
In 1972, Dr. Bricker and I collaborated with such notables as 
Jacques Bourgoignie, KH Hwang, and Carlos Espinel on the 
natriuretic factor in the serum of patients with chronic uremia.14 
Th is was to be our last published work together with Dr. Bricker 
as director of the Renal Division.
In 1972, Dr. Bricker accepted an appointment as head of the 
Department of Medicine at Albert Einstein College of Medicine, 
and Dr. Moore urged me to consider accepting the position of 
director of the Renal Division at Washington University. I was 
honored that he regarded my capabilities so highly. It was one of 
his last decisions on faculty matters (as he died later that year) 
and most surely altered the course of my career.
Like Carl Moore’s, my entire life as a physician-scientist 
has been spent at Washington University School of Medi-
cine. Th e history of this institution, its rich traditions, and 
its demand for excellence in both research and patient care 
have been the result of the revolutionary vision and spirit of 
strong leaders. It has been my good fortune to have known 
and collaborated with many of them. Th e list of young neph-
rologists of ‘the early days’ is endless, but I must mention 
such notables as J Bourgoignie (Belgium), EJ Dourhout-Mees 
(Th e Netherlands), HL Ellis (United States), L Guerra (Por-
tugal), S Guggenheim (United States), M Machado (Bra-
zil), ZB Orlowski (Poland), R Rieselbach (United States), 
M Purkerson (United States), AB Shaw (United Kingdom), 
E Slatopolsky (Argentina), and AM Robson (UK).
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